These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23557138)

  • 1. Reactive oxygen species responsive nanoprodrug to treat intracranial glioblastoma.
    Lee BS; Amano T; Wang HQ; Pantoja JL; Yoon CW; Hanson CJ; Amatya R; Yen A; Black KL; Yu JS
    ACS Nano; 2013 Apr; 7(4):3061-77. PubMed ID: 23557138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stimuli-responsive nanoprodrug of camptothecin kills glioblastoma cells.
    Lee BS; Nalla AK; Stock IR; Shear TC; Black KL; Yu JS
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5262-8. PubMed ID: 20655220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The self-assembling camptothecin-tocopherol prodrug: An effective approach for formulating camptothecin.
    Lu J; Liu C; Wang P; Ghazwani M; Xu J; Huang Y; Ma X; Zhang P; Li S
    Biomaterials; 2015 Sep; 62():176-87. PubMed ID: 26057133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles.
    Xin H; Sha X; Jiang X; Zhang W; Chen L; Fang X
    Biomaterials; 2012 Nov; 33(32):8167-76. PubMed ID: 22889488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous delivery of camptothecin-loaded PLGA nanoparticles for the treatment of intracranial glioma.
    Householder KT; DiPerna DM; Chung EP; Wohlleb GM; Dhruv HD; Berens ME; Sirianni RW
    Int J Pharm; 2015 Feb; 479(2):374-80. PubMed ID: 25562639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of submicron/nanoscale PLGA implants to deliver paclitaxel with enhanced pharmacokinetics and therapeutic efficacy in intracranial glioblastoma in mice.
    Ranganath SH; Fu Y; Arifin DY; Kee I; Zheng L; Lee HS; Chow PK; Wang CH
    Biomaterials; 2010 Jul; 31(19):5199-207. PubMed ID: 20350766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Prodrug of Camptothecin for Enhanced Treatment of Glioblastoma Multiforme.
    Checa-Chavarria E; Rivero-Buceta E; Sanchez Martos MA; Martinez Navarrete G; Soto-Sánchez C; Botella P; Fernández E
    Mol Pharm; 2021 Apr; 18(4):1558-1572. PubMed ID: 33645231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A GSH-Responsive Nanoprodrug System Based on Self-Assembly of Lactose Modified Camptothecin for Targeted Drug Delivery and Combination Chemotherapy.
    Hou C; Ma N; Shen Z; Chi G; Chao S; Pei Y; Chen L; Lu Y; Pei Z
    Int J Nanomedicine; 2020; 15():10417-10424. PubMed ID: 33376329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo.
    Zhan C; Wei X; Qian J; Feng L; Zhu J; Lu W
    J Control Release; 2012 Jun; 160(3):630-6. PubMed ID: 22410115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunction.
    Khan M; Yi F; Rasul A; Li T; Wang N; Gao H; Gao R; Ma T
    IUBMB Life; 2012 Sep; 64(9):783-94. PubMed ID: 22837216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of the effectiveness of poly(ε-caprolactone) lipid-core nanocapsules loaded with methotrexate on glioblastoma multiforme treatment.
    Pereira NRC; Loiola RA; Rodrigues SF; de Oliveira CP; Büttenbender SL; Guterres SS; Pohlmann AR; Farsky SH
    Int J Nanomedicine; 2018; 13():4563-4573. PubMed ID: 30154652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic modulation of glioblastoma with dichloroacetate.
    Michelakis ED; Sutendra G; Dromparis P; Webster L; Haromy A; Niven E; Maguire C; Gammer TL; Mackey JR; Fulton D; Abdulkarim B; McMurtry MS; Petruk KC
    Sci Transl Med; 2010 May; 2(31):31ra34. PubMed ID: 20463368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-order targeted brain tumor imaging by using an optical/paramagnetic nanoprobe across the blood brain barrier.
    Yan H; Wang L; Wang J; Weng X; Lei H; Wang X; Jiang L; Zhu J; Lu W; Wei X; Li C
    ACS Nano; 2012 Jan; 6(1):410-20. PubMed ID: 22148835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide grafted and self-assembled poly(γ-glutamic acid)-phenylalanine nanoparticles targeting camptothecin to glioma.
    Kulhari H; Telukutla SR; Pooja D; Shukla R; Sistla R; Bansal V; Adams DJ
    Nanomedicine (Lond); 2017 Jul; 12(14):1661-1674. PubMed ID: 28635550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive oxygen species and glutathione dual redox-responsive micelles for selective cytotoxicity of cancer.
    Chiang YT; Yen YW; Lo CL
    Biomaterials; 2015 Aug; 61():150-61. PubMed ID: 26002788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimuli-responsive polymer-doxorubicin conjugate: Antitumor mechanism and potential as nano-prodrug.
    Chen K; Cai H; Zhang H; Zhu H; Gu Z; Gong Q; Luo K
    Acta Biomater; 2019 Jan; 84():339-355. PubMed ID: 30503561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the PI3K pathway in the brain--efficacy of a PI3K inhibitor optimized to cross the blood-brain barrier.
    Salphati L; Heffron TP; Alicke B; Nishimura M; Barck K; Carano RA; Cheong J; Edgar KA; Greve J; Kharbanda S; Koeppen H; Lau S; Lee LB; Pang J; Plise EG; Pokorny JL; Reslan HB; Sarkaria JN; Wallin JJ; Zhang X; Gould SE; Olivero AG; Phillips HS
    Clin Cancer Res; 2012 Nov; 18(22):6239-48. PubMed ID: 22992516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Targeted and Responsive Nanoprodrug Delivery System for Synergistic Glioma Chemotherapy.
    Zhuo W; Wang W; Zhou W; Duan Z; He S; Zhang X; Yi L; Zhang R; Guo A; Gou X; Chen J; Huang N; Sun X; Qian Z; Wang X; Gao X
    Small; 2024 Jul; 20(30):e2400630. PubMed ID: 38431937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.